RNA Analytical Quality/Resources
-
Preventive Control Of Sequencing Through The Insert
3/4/2026
Understanding library size distributions helps prevent sequencing through the insert, reducing adapter read‑through. Explore how smear analysis guides optimal read‑length selection to avoid noise.
-
Exploring The Spatial Distribution Of mRNA-Lipid Nanoparticles Using MALDI MSI
4/23/2025
Learn how leveraging high-resolution MALDI-MSI can advance the development of lipid nanoparticle-based therapies, uncovering spatial biodistribution, pharmacokinetics, and organ-specific variability.
-
Selection And Evaluation Of Hybridization Capture Probes For LC/MS Analysis Of Oligonucleotides
4/23/2025
To overcome challenges in oligonucleotide LC/MS bioanalysis, consider optimizing probe design by evaluating alternative chemistries like PNA for improved recovery and chromatographic performance.
-
Novel Plasmid DNA-Encoded Poly(A) Tails For mRNA Synthesis
4/26/2024
Here, we evaluate the stability of these variant poly(A) regions and the biological activity of the mRNA containing the variant poly(A) tails made from these templates.
-
IR Spectral Signatures Of GC, AU, And GU Base Pairing In H2O-Based Buffer By MMS
5/22/2025
Explore a label-free approach to characterize RNA structure with high sensitivity. See how specific base pair types are resolved, providing a clearer picture of RNA folding.
-
Effects Of mRNA Capping Technologies
4/26/2024
This study compares two important mRNA capping technologies by evaluating the mRNA integrity, percent Cap1 content, dsRNA content, in vivo expression, and innate immune activation in mice.
-
Metabolite ID And Relative Quantification Of Oligonucleotides In Plasma
3/4/2022
This technical note describes the identification, relative quantification, and structural confirmation of the chain-shortened metabolites of a phosphorothioated oligonucleotide.
-
Accelerating IND-Enabling Studies With Automated Bioanalysis Workflows
9/2/2025
Reimagined as automation-first, bioanalysis shifts from being an Investigational New Drug (IND) bottleneck to a catalyst for innovation—helping companies move therapies forward with greater confidence.
-
Suitability Testing For IVT mRNA Analysis
11/20/2025
Automated capillary electrophoresis provides robust, precise analysis of IVT mRNA integrity, concentration, and size, demonstrating excellent method precision.
-
Engineered RNA Polymerases For Better Yield, Integrity, Capping, And dsRNA In IVT
11/4/2026
Two engineered non-T7 polymerase lineages face T7 in head-to-head IVT testing across four transcript lengths. Find out how capping, dsRNA, and translatability compare, and which lineage needs its own promoter.